company background image
KOY logo

Kobayashi Pharmaceutical DB:KOY Stock Report

Last Price

€33.00

Market Cap

€2.5b

7D

0%

1Y

-42.1%

Updated

24 Apr, 2024

Data

Company Financials +

Kobayashi Pharmaceutical Co., Ltd.

DB:KOY Stock Report

Market Cap: €2.5b

Kobayashi Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kobayashi Pharmaceutical
Historical stock prices
Current Share PriceJP¥33.00
52 Week HighJP¥57.00
52 Week LowJP¥28.00
Beta0.28
1 Month Change17.86%
3 Month Change-17.91%
1 Year Change-42.11%
3 Year Change-54.17%
5 Year Change-52.17%
Change since IPO96.49%

Recent News & Updates

Recent updates

Shareholder Returns

KOYDE Personal ProductsDE Market
7D0%4.4%1.7%
1Y-42.1%-2.0%2.3%

Return vs Industry: KOY underperformed the German Personal Products industry which returned -2.8% over the past year.

Return vs Market: KOY underperformed the German Market which returned 2.2% over the past year.

Price Volatility

Is KOY's price volatile compared to industry and market?
KOY volatility
KOY Average Weekly Movement7.7%
Personal Products Industry Average Movement4.7%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: KOY's share price has been volatile over the past 3 months.

Volatility Over Time: KOY's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
18863,534Kazumasa Kobayashiwww.kobayashi.co.jp

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company offers Ammeltz, a topical analgesic; Bluelet Decoral, a toilet bowl cleaner and freshener; Shoshugen, air freshener; Inochi no Haha, a women’s health medicine; Eyebon, an eye wash; Sarasaty lingerie soap; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toilet air freshener; and deodorizing air freshener, lens cleaner, and oral hygiene products. It also manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, and health foods; and processed synthetic resin products; markets nutritional supplements and skin care products through website and over the phone; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers.

Kobayashi Pharmaceutical Co., Ltd. Fundamentals Summary

How do Kobayashi Pharmaceutical's earnings and revenue compare to its market cap?
KOY fundamental statistics
Market cap€2.51b
Earnings (TTM)€122.37m
Revenue (TTM)€1.04b

20.5x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KOY income statement (TTM)
RevenueJP¥173.46b
Cost of RevenueJP¥77.08b
Gross ProfitJP¥96.38b
Other ExpensesJP¥76.04b
EarningsJP¥20.34b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 10, 2024

Earnings per share (EPS)274.08
Gross Margin55.56%
Net Profit Margin11.73%
Debt/Equity Ratio0%

How did KOY perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

34%

Payout Ratio

Does KOY pay a reliable dividends?

See KOY dividend history and benchmarks
When do you need to buy KOY by to receive an upcoming dividend?
Kobayashi Pharmaceutical dividend dates
Ex Dividend DateJun 27 2024
Dividend Pay DateSep 09 2024
Days until Ex dividend63 days
Days until Dividend pay date137 days

Does KOY pay a reliable dividends?

See KOY dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.